Genencor and BRAIN establish research collaboration

BRAIN will provide Genencor access to these technologies and especially to its vast metagenome resources of some 150 million genes of yet uncultured microorganisms.

Genencor, a division of Danisco A/S and BRAIN AG, a leading European industrial biotechnology company, located in Zwingenberg, Germany, join forces in the field of the biobased fermentative production of industrially relevant biochemicals from renewable raw materials. Genencor will use its extensive capabilities in metabolic pathway engineering and biomanufacturing of industrial bio-products and BRAIN AG’s world leading expertise in the fields of metagenomics and screening technologies, to pursue product targets for the chemical industry.